Currently out of the existing stock ratings of Jason Cassorla, 39 are a BUY (76.47%), 12 are a HOLD (23.53%).

Jason Cassorla

Work Performance Price Targets & Ratings Chart

Analyst Jason Cassorla works at CITI with a stock forecast success ratio of 39.09% fulfilled within 160.55 days on average.

Jason Cassorla’s has documented 97 price targets and ratings displayed on 11 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on UHS, Universal Health Services at 29-Feb-2024.

Wall Street Analyst Jason Cassorla

Analyst best performing recommendations are on CANO (CANO HEALTH).
The best stock recommendation documented was for CANO (CANO HEALTH) at 8/10/2022. The price target of $7 was fulfilled within 14 days with a profit of $2.26 (47.68%) receiving and performance score of 34.06.

Average potential price target upside

AGTI Agiliti BHG Bright Health Group CANO Cano Health CYH Community Health Systems HCA HCA Holdings SGRY Surgery Partners THC Tenet Healthcare CLOV Clover Health Investments Corp UHS Universal Health Services EHAB Enhabit . INNV InnovAge Holding Corp

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

10

$-0.03 (-0.30%)

16

1 months 11 days ago

3/5 (60%)

$0.09 (0.91%)

19

Sell

11

$0.97 (9.67%)

18

7 months 13 days ago

1/3 (33.33%)

$2.29 (26.29%)

49

Hold

13

$2.97 (29.61%)

20

8 months 3 days ago

0/5 (0%)

$1.86 (16.70%)

Buy

13

$6.51 (100.31%)

28

8 months 3 days ago

1/3 (33.33%)

$4.47 (25.29%)

17

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Jason Cassorla is most bullish on?

Potential upside of $21.37 has been obtained for UHS (UNIVERSAL HEALTH SERVICES)

Which stock is Jason Cassorla is most reserved on?

Potential downside of -$49.02 has been obtained for HCA (HCA HOLDINGS)

What Year was the first public recommendation made by Jason Cassorla?

On 2017

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?